Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-25T23:32:18.168Z Has data issue: false hasContentIssue false
  • English
  • Français

A content analysis of health technology assessment programs in Latin America

Published online by Cambridge University Press:  22 October 2009

Luis E. Arellano ,
Mercedes Reza ,
Juan Antonio Blasco  and
Elena Andradas
Luis E. Arellano
Affiliation:
Unidad de Evaluación de Tecnologías Sanitarias – Agencia Laín Entralgo
Mercedes Reza
Affiliation:
Unidad de Evaluación de Tecnologías Sanitarias – Agencia Laín Entralgo
Juan Antonio Blasco
Affiliation:
Unidad de Evaluación de Tecnologías Sanitarias – Agencia Laín Entralgo
Elena Andradas
Affiliation:
Unidad de Evaluación de Tecnologías Sanitarias – Agencia Laín Entralgo
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: Health Technology Assessment (HTA) is a relatively new concept in Latin America (LA). The objectives of this exploratory study were to identify HTA programs in LA, review HTA documents produced by those programs, and assess the extent to which HTA aims are being achieved.

Methods: An electronic search through two databases was performed to identify HTA programs in LA. A content analysis was performed on HTA documents (n = 236) produced by six programs between January 2000 and March 2007. Results were analyzed by comparing document content with the main goals of HTA.

Results: The number of HTA documents increased incrementally during the study period. The documents produced were mostly short HTA documents (82 percent) that assessed technologies such as drugs (31 percent), diagnostic and/or screening technologies (18 percent), or medical procedures (18 percent). Two-thirds (66 percent) of all HTA documents addressed issues related to clinical effectiveness and economic evaluations. Ethical, social, and/or legal issues were rarely addressed (<1 percent). The two groups most often targeted for dissemination of HTA information were third-party payers (55 percent) or government policy makers (41 percent).

Conclusions: This study showed that while HTA programs in LA have attempted to address the main goals of HTA, they have done so through the production of short documents that focus on practical high-technology areas of importance to two specific target groups. Clinical and economic considerations still take precedence over ethical, social, and/or legal issues. Thus, an integrated conceptual framework in LA is wanting.

Keywords

Health technology assessmentLatin AmericaContent analysis
Type
Research Reports
Information
International Journal of Technology Assessment in Health Care , Volume 25 , Issue 4 , October 2009 , pp. 570 - 576
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Banta, HD, Oortwijn, WJ, van Beekum, WT. The organization of health care technology assessment in the Netherlands. The Hague: Rathenau Institute; 1995.Google Scholar
2. Banta, D, Oortwijn, W. Special issue: Health technology assessment in the European Union. Int J Technol Assess Health Care. 2000;16:2.Google Scholar
3. Banta, D, Oortwijn, T. Health technology assessment and health care in the European Union. TA Datenbank Nachrichten. 2001;10:29–37.Google Scholar
4. Battista, RN, Lance, JM, Lehoux, P, et al. Health technology assessment and the regulation of medical devices and procedures in Quebec: Synergy, collusion or collision? Int J Technol Assess Health Care. 1999;15:593–601.CrossRefGoogle ScholarPubMed
5. Bero, LA, Jadad, AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med. 1997;127:37–42.CrossRefGoogle ScholarPubMed
6. Cookson, R, Maynard, A. Health technology assessment in Europe. Improving clarity and performance. Int J Technol Assess Health Care. 2000;16:639–650.CrossRefGoogle ScholarPubMed
7. Hailey, D, Corabian, P, Harstall, C, et al. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16:651–656.CrossRefGoogle ScholarPubMed
8. Hennen, L. TA in biomedicine and healthcare: From clinical evaluation to policy consulting. TA Datenbank Nachrichten. 2001;10:13–22.Google Scholar
9. International Network of Agencies for Health Technology Assessment (INAHTA). Health Technology Assessment (HTA) glossary. 1st ed. Stockholm: INAHTA; 2006.Google Scholar
10. Johri, M, Lehoux, P. The great escape? Health technology assessment as a means of cost control. Int J Technol Assess Health Care. 2003;19:179–193.CrossRefGoogle Scholar
11. Lehoux, P, Blume, S. Technology assessment and the socio politics of health technologies. J Health Polit Policy Law. 2000;25:1083–1120.CrossRefGoogle Scholar
12. Lehoux, P, Tailliez, S, Denis, J-L, Hivon, M. Redefining HTA in Canada: Diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20:325–336.CrossRefGoogle ScholarPubMed
13. Leys, M. Technology assessment in de gezondheidszorg. Betere Praktijk door een duidelijker begrippenapparaat. Acta Hospitalia. 1997;4:19–32.Google Scholar
14. Mowatt, G, Grant, AM, Bower, DJ, et al. Timing of assessment of fast-changing health technologies. In: Stevens, A, Abrams, K, Brazier, J, et al. , eds. The advanced handbook of methods in evidenced-based health care. London: SAGE Publications; 2001:471–484.CrossRefGoogle Scholar
15. Office of Technology Assessment. Development of medical technology: Opportunities for assessment. Washington, DC: Office of Technology Assessment; 1975.Google Scholar
16. Pan American Health Organization (PAHO). Developing health technology assessment in Latin America and the Caribbean. Annapolis Junction, MD: PAHO; 1998.Google Scholar
17. Perry, S, Gardner, E, Thamer, M. The status of health technology assessment worldwide: Results from an international survey. Int J Technol Assess Health Care. 1997;13:81–98.CrossRefGoogle ScholarPubMed
18. Perry, S, Marx, ES. What technologies for health care in developing countries? vol. 13. Geneva: World Health Forum; 1992:356–362.Google ScholarPubMed
19. Wilensky, GR. Comparative clinical effectiveness: Leveraging innovation to improve health care quality for all Americans. Presented on behalf of Project HOPE before the Committee on Finance of the United States Senate, July 17, 2008.Google Scholar